 The purposes of this study are: 1 to decrease the side effects due to the chemotherapy used to treat the bone marrow; and 2 to increase the number of tumor cells killed. There will be up to 55 patients enrolled in this study at Emory University. The expected duration of each subjects participation in this study will be for two years. 